Cargando…
2782. In vitro activity of ceftazidime-avibactam against Gram-negative strains in patients with bacteremia and skin and soft-tissue infections in Colombia 2019-2021
BACKGROUND: In vitro activity of Ceftazidime-avibactam (CAZ-AVI) in patients with bacteremia and skin and soft tissue infections (SSTIs) is unknown. The study aimed to analyze the in vitro antimicrobial activity of CAZ-AVI and other antimicrobials against Gram-negative bacilli collected in hospitals...
Autores principales: | Lemos-Luengas, Elkin, Rentería-Valoyes, Sixta Romelia, Muñoz, Diana Marcela Almario, Orozco, Carlos David Gamboa, Gómez, Juan Camilo Olivella, Ramos-Castaneda, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678711/ http://dx.doi.org/10.1093/ofid/ofad500.2393 |
Ejemplares similares
-
In vitro activity of ceftazidime-avibactam against Gram-negative strains in patients with complicated urinary tract infection and complicated intra-abdominal infection in Colombia 2014-2018
por: Lemos-Luengas, Elkin V., et al.
Publicado: (2022) -
Ceftazidime-avibactam
por: Matesanz, Mayra, et al.
Publicado: (2021) -
Ceftazidime-avibactam
por: Herrero, Francisco Sanz
Publicado: (2022) -
616. Evaluation of In Vitro Susceptibility to Ceftazidime/Avibactam of Clinical Isolates of Carbapenem Nonsusceptible Gram-Negative Bacilli from Colombia
por: Appel, Tobias M, et al.
Publicado: (2019) -
Investigation of ceftazidime-avibactam susceptibility in clinical isolates of gram-negative bacteria
por: DUMLU, Rıdvan, et al.
Publicado: (2022)